ホモシスチン尿症市場は、2021 年の 5,658 万米ドルから 2028 年までに 7,396 万米ドルに達すると予測されています。 2021 年から 2028 年にかけて 3.9% の CAGR で増加すると推定されています。
ホモシスチン尿症は、身体が特定のタンパク質構成要素 (アミノ酸) を正しく消化できない遺伝的疾患です。ホモシスチン尿症にはさまざまなタイプがあり、それぞれに独自の兆候や症状、および遺伝性の病因があります。近視(近視)、目の前部の水晶体の脱臼、不規則な血液凝固のリスクの増加、骨折しやすい脆い骨(骨粗鬆症)またはその他の骨格異常が、ホモシスチン尿症の最も一般的な形態を定義します。影響を受ける人の中には、発達の遅れや学習困難を抱えている人もいます。
戦略的洞察
ホモシスチン尿症市場の成長は、ビタミン B6 とビタミン B12 の欠乏症の増加に起因していると考えられています。遺伝性代謝障害の有病率の増加。しかし、さまざまな希少疾患や遺伝性代謝疾患に関する認識の欠如が市場の成長を妨げています。
ホモシスチン尿症市場の収益性の高い地域
市場洞察ビタミン B6 およびビタミン B12 欠乏症の増加がホモシスチン尿症市場を牽引< /h3>
ビタミン B6 およびビタミン B12 欠乏パターンの増加は、貧血、巨赤芽球性貧血、小球性貧血、およびある種の代謝障害などのいくつかの障害を引き起こし、予測期間中の市場の成長を後押しすると予想されます。ビタミンB6療法はホモシスチン尿症に対する効果的な治療法であると考えられているため、このビタミンが欠乏すると症状が悪化する可能性があります。ピリドキシン (ビタミン B6) は、β シンターゼの補因子として機能し、いくつかのミスセンス変異を安定化するためのシャペロンとして機能します。ホモシスチン尿症患者の中にはピリドキシン療法によく反応する人もいます。ピリドキシン療法はホモシステイン値の低下に役立ち、それによって症状が軽減されます。したがって、ホモシスチン尿症を治すために利用できる治療法は限られているため、ビタミンB6はホモシスチン尿症の管理に不可欠であると考えられています。この酵素の欠乏は貧血および小球性貧血を引き起こします。貧血の有病率の上昇により、予測期間中の市場の成長が促進されると予想されます。たとえば、世界保健機関によると、貧血は 16 億 2,000 万人以上の人口、つまり人口の 24.8% に影響を及ぼしています。貧血の主な原因は、不適切な食事とビタミンB6、B9、B12などの欠乏です。主に、ビタミン B6 欠乏が貧血の主な原因です。したがって、ビタミン B6 欠乏症の症例の増加と、ビタミン B6 欠乏症に関連する疾患の高い有病率が、予測期間中の市場の成長をサポートすると予想されます。
メソッドベースの洞察
世界のホモシスチン尿症市場は、方法に基づいて治療と診断に分かれています。治療セグメントは、2021年の市場でより大きなシェアを占めました。さらに、ホモシスチン尿症の既存の治療の使用と新しい治療法の研究開発の増加により、同じセグメントは予測期間中に市場でより高いCAGRを記録すると予想されます。
方法別ホモシスチン尿症市場 - 2021 年および 2028 年
エンドユーザーベースの洞察
エンドユーザーに基づいた世界のホモシスチン尿症市場は、次のように分類されます。診断および画像研究所、病院および診療所、専門診療所、および学術研究機関。 2021年には、診断および画像検査室部門が市場で最大のシェアを占めました。さらに、診断および画像検査機関における遺伝性代謝異常症の診断の増加により、この分野は 2021 年から 2028 年にかけて 4.2% という最高の CAGR を記録すると予想されています。
製品の発売と承認は、企業が一般的に採用する戦略です。世界的な拠点と製品ポートフォリオを拡大します。さらに、ホモシスチン尿症市場のプレーヤーは、顧客層を拡大するためのパートナーシップ戦略に焦点を当てており、これにより世界中でブランド名を維持することが可能になります。
レポートは、ホモシスチン尿症市場を次のように分類します
ホモシスチン尿症市場 - 方法別
- 治療法
- ピリドキシン
- ベタイン
- その他
- 診断
- 遺伝子検査
- アミノ酸スクリーニング検査
- 肝臓酵素検査
- その他
< /ul>
ホモシスチン尿症市場 - エンドユーザー別
- 病院および診療所
- 診断および画像検査機関
- 専門クリニック
- 学術機関および研究機関
ホモシスチン尿症市場 - 地理別
- 北米
- 米国< /li>
- カナダ
- メキシコ
- ヨーロッパ
- イギリス
- ドイツ
- フランス
- イタリア
- スペイン
- その他のヨーロッパ
- アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
li>
- 中東およびアフリカ
- アラブ首長国連邦
- サウジアラビア
- 南アフリカ
- 残り中東およびアフリカ諸国
- 中南米
- ブラジル
- アルゼンチン
- 南米および中央アメリカのその他の地域中米
会社概要
- BASF SE
- 華中製薬
- ファイザー株式会社
- MYLAN NV
- Aeglea BioTherapeutics
- Amino GMBH
- 花王株式会社
- DSM Corporation< /li>
- オーファン テクノロジーズ
- フレゼニウス カビ AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global Homocystinuria market is expected to reach US$ 73,960.22 thousand by 2028 from US$ 56,589.20 thousand in 2021; it is estimated to grow at a CAGR of 3.9% during 2021-2028.
Emergence of human enzyme therapeutics and enzyme replacement therapy to treat rare disorders is one of the future trends of homocystinuria market. Enzyme replacement therapy and enzyme therapeutics is a type of novel drug therapy in which therapeutic enzymes are used to treat chronic and life-threatening diseases such as cancer, idiosyncratic disorders, and rare disorders. Furthermore, if an enzyme is not functioning properly in the body, then enzyme replacement therapy is used for replacing the enzyme that is deficient in the body. Enzymes have a predominant role in pharmaceutical industries and drug development as they treat various disorders. The advancements in the field of protein technology, recombinant DNA technology, enzyme immobilization, and nanotechnology have provided a solid platform for the use of enzymes in the treatment of various disorders.
The growth of the Homocystinuria market is mainly attributed to factors such as the increasing prevalence of inherited metabolic disorders coupled with rise in vitamin B6 and Vitamin B12 deficiencies. However, the lack of awareness about various rare disorders and inherited metabolic disorders is hindering the market growth.
The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market in this region is expected to grow significantly in countries such as, China, Japan and India. The market is driven by increase in prevalence of inherited metabolic disorders, rise in government initiatives to manage rare diseases across the region along with increase in diagnostic tests across the region such as new born screening test etc. Therefore, the region holds huge potential for the homocystinuria market players to grow during the forecast period.
Homocystinuria is an inherited disorder in which the body is unable to process certain building blocks of proteins (amino acids) properly. There are multiple forms of homocystinuria, which are distinguished by their signs and symptoms and genetic cause. The most common form of homocystinuria is characterized by nearsightedness (myopia), dislocation of the lens at the front of the eye, an increased risk of abnormal blood clotting, and brittle bones that are prone to fracture (osteoporosis) or other skeletal abnormalities. Some affected individuals also have developmental delay and learning problems.
The List of Companies - Homocystinuria Market
- BASF SE
- HUAZHONG PHARMACEUTICAL
- Pfizer Inc.
- MYLAN N.V
- Aeglea BioTherapeutics
- Amino GMBH
- KAO Corporation
- DSM Corporation
- Orphan Technologies
- Fresenius Kabi AG.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)